Video

Mitigating Racial Disparities in Oncology

Chasity M. Washington, MPH, CHES, discusses ways to mitigate racial disparities in oncology.

Chasity M. Washington, MPH, CHES, director, Center for Cancer Health Equity, The Ohio State University Comprehensive Cancer Center–James, discusses ways to mitigate racial disparities in oncology.

In an effort to mitigate racial disparities in oncology, a number of actions must be taken, says Washington. The best place to start is by reviewing internal data within each institution, such as policies and procedures, ensuring that they are well-disposed to all populations. 

Many institutions have been doing a great job with this, although, more still has to be done, Washington adds.

Furthermore, the patient population that is treated at an institution should be reflective of the greater community. If a certain population is seeking treatment elsewhere or not at all, faculty should work to improve their outreach in addition to community education and engagement, Washington concludes.

Related Videos
Binod Dhakal, MD
Jill Corre, PharmD, PhD
Saad Z. Usmani, MD, MBA, FACP, FASCO
Ashraf Z. Badros, MBCHB
Thierry Andre, MD, professor, medical oncology, Sorbonne Université; head, Medical Oncology Department, Saint Antoine Hospital
Sanjay Popat, BSc, MBBS, FRCP, PhD, consultant medical oncologist, The Royal Marsden Hospital; professor, thoracic oncology, the Institute of Cancer Research
Toni Choueiri, MD, director, Lank Center for Genitourinary Oncology, co-leader, kidney cancer program, Dana-Farber Cancer Institute; Jerome and Nancy Kohlberg Chair, professor, medicine, Harvard Medical School
Angeles A. Secord, MD, MHSc, professor, obstetrics and gynecology, Duke Cancer Institute, discusses findings from the phase 2 PICCOLO trial (NCT05041257) investigating mirvetuximab soravtansine-gynx (Elahere) in patients with recurrent, platinum-sensitive ovarian cancer with high folate receptor alpha (FRα) expression.
Nancy U. Lin, MD, associate chief, Division of Breast Oncology, Susan F. Smith Center for Women’s Cancers, director, Metastatic Breast Cancer Program, director, Program for Patients with Breast Cancer Brain Metastases, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
Nicolas Girard, MD, professor, respiratory medicine, Versailles Saint Quentin University; head, Curie-Montsouris Thorax Institute, chair, Medical Oncology Department, Institut Curie